Company Profile

Renova Life Inc
Profile last edited on: 12/6/2013      CAGE: 5D4B3      UEI: ZSXQFC24VAU5

Business Identifier: Animal embryo biotechnologies, transgenic animal production, animal cloning, in vitro fertilization, embryo cryopreservation and embryonic stem cell.
Year Founded
2008
First Award
2013
Latest Award
2013
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

387 Technology Drive Suite 2116
College Park, MD 20742
   (301) 405-0298
   info@renovalife.com
   www.renovalife.com
Location: Single
Congr. District: 05
County: Prince Georges

Public Profile

Renova Lfe is focused to research and innovations in animal reproductive biotechnologies, focused on bovine, equine and rabbit models. These technologies include DNA microinjection, embryonic stem cells, iPS cells, cell specific differentiation, in vitro fertilization (IVF), nuclear transfer (NT, also known as "cloning"), and other related technologies. RLI has developed innovative embryo medium products for bovine and equine reproduction and fertility applications including Embryo Flushing Plus, Embryo Flushing Supreme, Embryo Washing and Holding, Oocyte Aspiration Plus, and Oocyte Washing Prior to IVM. This series is designed for flushing embryos (in vivo) and collecting oocytes designated for in vitro fertilization (IVF). All products are made in the United States and have met bovine IVF and embryo culture quality control standards. Product quality is guaranteed. RLI also provides embryos and related services, such as IVF testing and PCR sexing. Animal biotechnologies have tremendous opportunities in agricultural, biomedical and pharmaceutical applications. For example, embryonic stem cells in animals are the inevitable steps before we can apply human ES cell therapies in humans. Nuclear transfer, or so called animal cloning, help to preserve elite genetics (including transgenic founders) in both laboratory and domestic animals, such as rabbits, pigs, goats, and cattle. The Company's mission is to develop novel animal reproductive biotechnologies, focused on bovine, equine and rabbit models, and to provide quality animal embryos, embryonic stem cell related products and services to the agricultural, pharmaceutical industry as well as animal science and biomedical research community.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2013 1 NIH $155,986
Project Title: Non-Invasive Method to Evaluate the Quality of Human Oocytes and Embryos

Key People / Management

  Fuliang Du -- President

  Lisa LI

  Xingqi John Zhang